- Our Team
- For Patients
- Treatments & Services
- Medical Professionals
Clinical Trial
Clinical Trial Search
Trial Protocol ID XPORT-MF-034
Trial Description
A Phase 1/3 Study to Evaluate Efficacy and Safety of Selinexor, a Selective Inhibitor of Nuclear Export, in Combination With Ruxolitinib in Treatment-naïve Patients With Myelofibrosis
Contact us regarding Clinical Trials at MOHRSCH@usoncology.com or call us at 877-664-7724
Investigator
- Mohit Narang, M.D.
Disease Types
Sponsor
- Karyopharm Therapeutics Inc.
ClinicalTrials.gov NCT ID
- NCT04562389